Product Information
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) is a generic product labeled by Aurobindo Pharma Limited, priced at $1.0939 per EA under NDC 65862094760. Its NADAC has been published 402 times since Jan 23, 2019.
FDA first approved this application on Jul 24, 2018. Its Orange Book therapeutic-equivalence code is AT2.
DORZOLAMIDE-TIMOLOL 2-0.5%(PF)
Dorzolamide Hydrochloride and Timolol Maleate Preservative FreeStrength
20; 5 mg/mL; mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862094760
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA207630FDA Approved
7/24/2018
TE Code
AT2
On Market Since
7/24/2018
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has been published 402 times since Jan 23, 2019, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0939 per EA |
|---|---|
| All-time high | $2.2200 (Feb 13, 2019) |
| All-time low | $0.9746 (Nov 20, 2024) |
| 52-week high | $1.1367 |
| 52-week low | $1.0471 |
| Median price | $1.7426 |
| Average price | $1.6203 |
| Largest weekly change | +40.7% (Jun 19, 2024) |
| Weeks tracked | 402 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Preservative Free market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dorzolamide Hydrochloride and Timolol Maleate Preservative Free market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL 2-0.5%(PF), manufactured by Aurobindo Pharma Limited, is $1.0939 per EA (NDC 65862094760), effective Sep 30, 2026.
How has the price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has declined 50.7%. It has been tracked across 402 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
Since Jan 23, 2019, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has ranged from a low of $0.9746 (Nov 20, 2024) to a high of $2.2200 (Feb 13, 2019), with a median of $1.7426 per EA.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?
DORZOLAMIDE-TIMOLOL 2-0.5%(PF) (NDC 65862094760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.